James Birmingham

Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series

Peter A. Nigrović, Melissa L. Mannion, Femke H. M. Prince et al. · Arthritis & Rheumatism · 2010 · 464 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +10

Emergent high fatality lung disease in systemic juvenile arthritis

Vivian E Saper, Guangbo Chen, Gail Deutsch et al. · Annals of the Rheumatic Diseases · 2019 · 216 citations · Full text

Medicine, Pathology, Hypersensitivity +10

Therapeutic Role of Anakinra, an Interleukin-1 Receptor Antagonist, in the Management of Secondary Hemophagocytic Lymphohistiocytosis/Sepsis/Multiple Organ Dysfunction/Macrophage Activating Syndrome in Critically Ill Children*

Surender Rajasekaran, Katherine Kruse, Karen Kovey et al. · Pediatric Critical Care Medicine · 2014 · 196 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +14

<i>HLA-DRB1*11</i> and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis

Michael J. Ombrello, Elaine F. Remmers, Ioanna Tachmazidou et al. · Proceedings of the National Academy of Sciences · 2015 · 185 citations · Full text

Life Sciences, Genetics, Immunology +17

Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254)

Virginia B. Kraus, James Birmingham, Thomas Stäbler et al. · Osteoarthritis and Cartilage · 2012 · 174 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +11